Now RFK Jr. Has Chance to Steer Vaccine and Health Policy
Longtime Democrat and vaccine skeptic Robert F. Kennedy Jr.is poised to take a health role in a new Trump administration and wage war on chronic disease by attacking everything from fluoride in drinking water to sugary drinks paid for by food stamps.
Trump campaign quietly distances itself from RFK Jr after new vaccine safety comments
Donald Trump’s team appeared to be quietly distancing itself from Robert F Kennedy Jr in the immediate aftermath of the election amid speculation that the former presidential candidate could be handed control of US public health agencies.
Here’s What An RFK Jr. Health Role In A Trump Administration Could Look Like: Vaccine Skepticism, Fluoride Ban
Kennedy has suggested he would ban fluoride in drinking water after being appointed to an unspecified health post in former President Donald Trump’s upcoming second administration.
Vaccine Stocks Drop on Worries About an RFK Jr. Role
It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Stocks of vaccine-makers were underperforming on Wednesday,
Hear what RFK Jr. said about vaccines post-election
Former presidential candidate Robert F. Kennedy Jr. discusses his plan for vaccine safety following President-elect Donald Trump’s victory. CNN’s Meg Tirrell explains how the US currently monitors vaccine safety and efficacy.
RFK Jr: ‘We’re not gonna take vaccines away from anybody’
We’re not going to take vaccines away from anybody,” he told NPR in an interview this morning after Trump’s overnight victory. He repeated the message a few hours later in an interview with MSNBC. Instead,
RFK Jr. talks health care agenda following Trump win: ‘I’m not going to take away vaccines’
Robert F. Kennedy Jr., who may play a key role in overseeing health care in a second Trump administration, spoke to NBC News’ Vaughn Hillyard about his current views on vaccines, fluoride in water, and more.
Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
Africa health body calls on Trump to honour US vaccine pledges
Africa's main public health body said it is seeking assurances that U.S. President-elect Donald Trump's administration will ...
BioSpace2h
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, But RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
Mpox vaccine doses divvied up for 9 African countries
An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.
FiercePharma3h
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Novavax, UK terminate vaccine supply agreement
Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...
The Associated Press on MSN16h
UK doctor gets 31 years for poisoning mother's partner with fake COVID vaccine
A British doctor who was disgruntled about his inheritance and injected his mother’s boyfriend with poison presented as a ...
Whooping cough vaccine vigilance is slipping in WA
Last week, the state reported that so far this year, 1,099 cases of whooping cough have been reported compared to just 45 at ...
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.